Cargando…
Advances in Membrane-Bound Catechol-O-Methyltransferase Stability Achieved Using a New Ionic Liquid-Based Storage Formulation
Membrane-bound catechol-O-methyltransferase (MBCOMT), present in the brain and involved in the main pathway of the catechol neurotransmitter deactivation, is linked to several types of human dementia, which are relevant pharmacological targets for new potent and nontoxic inhibitors that have been de...
Autores principales: | Gonçalves, Ana M., Sousa, Ângela, Pedro, Augusto Q., Romão, Maria J., Queiroz, João A., Gallardo, Eugénia, Passarinha, Luís A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266758/ https://www.ncbi.nlm.nih.gov/pubmed/35806268 http://dx.doi.org/10.3390/ijms23137264 |
Ejemplares similares
-
Thermofluor-Based Optimization Strategy for the Stabilization of Recombinant Human Soluble Catechol-O-Methyltransferase
por: Gonçalves, Ana M., et al.
Publicado: (2022) -
Discovery of Small Molecules as Membrane-Bound Catechol-O-methyltransferase Inhibitors with Interest in Parkinson’s Disease: Pharmacophore Modeling, Molecular Docking and In Vitro Experimental Validation Studies
por: Cruz-Vicente, Pedro, et al.
Publicado: (2021) -
An artificial neural network for membrane-bound catechol-O-methyltransferase biosynthesis with Pichia pastoris methanol-induced cultures
por: Pedro, Augusto Q, et al.
Publicado: (2015) -
Development of fed-batch profiles for efficient biosynthesis of catechol-O-methyltransferase
por: Espírito Santo, G.M., et al.
Publicado: (2014) -
Ionic-liquid-based approaches to improve biopharmaceuticals downstream processing and formulation
por: Almeida, Catarina, et al.
Publicado: (2023)